Systematic review of N-acetylcysteine in the treatment of addictions

Bibliographic Details
Main Author: Asevedo,Elson
Publication Date: 2014
Other Authors: Mendes,Ana C., Berk,Michael, Brietzke,Elisa
Format: Article
Language: eng
Source: Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200168
Summary: Objective: To conduct the first systematic literature review of clinical trials of N-acetylcysteine (NAC) for the treatment of substance abuse disorders and addictive behaviors. Methods: A search of the MEDLINE, Embase and PsycINFO databases was conducted. The inclusion criteria for the review were clinical trials that used NAC in the treatment of a disorder related to substance use and/or addictive behaviors, limited to texts in English, Spanish, or French. The selected studies were evaluated with respect to type of trial, sample size, diagnostic input, intervention, length of follow-up, outcome variables, and results. Results: Nine studies analyzing a total of 165 patients met the eligibility criteria and were included in qualitative analysis. These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and pathological gambling (one study). Five of these trials were double-blind, randomized, and placebo-controlled. Conclusions: The studies analyzed suggest a potential role for NAC in the treatment of addiction, especially of cocaine and cannabis dependence. These results are concordant with the hypothesis of the involvement of glutamatergic pathways in the pathophysiology of addiction.
id ABP-1_b14b9366af1557295bb073bed85dba1e
oai_identifier_str oai:scielo:S1516-44462014000200168
network_acronym_str ABP-1
network_name_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository_id_str
spelling Systematic review of N-acetylcysteine in the treatment of addictionsDrug dependenceaddictive behaviorsN-acetylcysteineglutamatergic receptorssmoking Objective: To conduct the first systematic literature review of clinical trials of N-acetylcysteine (NAC) for the treatment of substance abuse disorders and addictive behaviors. Methods: A search of the MEDLINE, Embase and PsycINFO databases was conducted. The inclusion criteria for the review were clinical trials that used NAC in the treatment of a disorder related to substance use and/or addictive behaviors, limited to texts in English, Spanish, or French. The selected studies were evaluated with respect to type of trial, sample size, diagnostic input, intervention, length of follow-up, outcome variables, and results. Results: Nine studies analyzing a total of 165 patients met the eligibility criteria and were included in qualitative analysis. These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and pathological gambling (one study). Five of these trials were double-blind, randomized, and placebo-controlled. Conclusions: The studies analyzed suggest a potential role for NAC in the treatment of addiction, especially of cocaine and cannabis dependence. These results are concordant with the hypothesis of the involvement of glutamatergic pathways in the pathophysiology of addiction. Associação Brasileira de Psiquiatria2014-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200168Brazilian Journal of Psychiatry v.36 n.2 2014reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)instname:Associação Brasileira de Psiquiatria (ABP)instacron:ABP10.1590/1516-4446-2013-1244info:eu-repo/semantics/openAccessAsevedo,ElsonMendes,Ana C.Berk,MichaelBrietzke,Elisaeng2014-06-27T00:00:00Zoai:scielo:S1516-44462014000200168Revistahttp://www.bjp.org.br/ahead_of_print.asphttps://old.scielo.br/oai/scielo-oai.php||rbp@abpbrasil.org.br1809-452X1516-4446opendoar:2014-06-27T00:00Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)false
dc.title.none.fl_str_mv Systematic review of N-acetylcysteine in the treatment of addictions
title Systematic review of N-acetylcysteine in the treatment of addictions
spellingShingle Systematic review of N-acetylcysteine in the treatment of addictions
Asevedo,Elson
Drug dependence
addictive behaviors
N-acetylcysteine
glutamatergic receptors
smoking
title_short Systematic review of N-acetylcysteine in the treatment of addictions
title_full Systematic review of N-acetylcysteine in the treatment of addictions
title_fullStr Systematic review of N-acetylcysteine in the treatment of addictions
title_full_unstemmed Systematic review of N-acetylcysteine in the treatment of addictions
title_sort Systematic review of N-acetylcysteine in the treatment of addictions
author Asevedo,Elson
author_facet Asevedo,Elson
Mendes,Ana C.
Berk,Michael
Brietzke,Elisa
author_role author
author2 Mendes,Ana C.
Berk,Michael
Brietzke,Elisa
author2_role author
author
author
dc.contributor.author.fl_str_mv Asevedo,Elson
Mendes,Ana C.
Berk,Michael
Brietzke,Elisa
dc.subject.por.fl_str_mv Drug dependence
addictive behaviors
N-acetylcysteine
glutamatergic receptors
smoking
topic Drug dependence
addictive behaviors
N-acetylcysteine
glutamatergic receptors
smoking
description Objective: To conduct the first systematic literature review of clinical trials of N-acetylcysteine (NAC) for the treatment of substance abuse disorders and addictive behaviors. Methods: A search of the MEDLINE, Embase and PsycINFO databases was conducted. The inclusion criteria for the review were clinical trials that used NAC in the treatment of a disorder related to substance use and/or addictive behaviors, limited to texts in English, Spanish, or French. The selected studies were evaluated with respect to type of trial, sample size, diagnostic input, intervention, length of follow-up, outcome variables, and results. Results: Nine studies analyzing a total of 165 patients met the eligibility criteria and were included in qualitative analysis. These studies evaluated the role of NAC in cocaine dependence (three studies), cannabis dependence (two studies), nicotine dependence (two studies), methamphetamine addiction (one study), and pathological gambling (one study). Five of these trials were double-blind, randomized, and placebo-controlled. Conclusions: The studies analyzed suggest a potential role for NAC in the treatment of addiction, especially of cocaine and cannabis dependence. These results are concordant with the hypothesis of the involvement of glutamatergic pathways in the pathophysiology of addiction.
publishDate 2014
dc.date.none.fl_str_mv 2014-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200168
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000200168
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-4446-2013-1244
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria
dc.source.none.fl_str_mv Brazilian Journal of Psychiatry v.36 n.2 2014
reponame:Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
instname:Associação Brasileira de Psiquiatria (ABP)
instacron:ABP
instname_str Associação Brasileira de Psiquiatria (ABP)
instacron_str ABP
institution ABP
reponame_str Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
collection Brazilian Journal of Psychiatry (São Paulo. 1999. Online)
repository.name.fl_str_mv Brazilian Journal of Psychiatry (São Paulo. 1999. Online) - Associação Brasileira de Psiquiatria (ABP)
repository.mail.fl_str_mv ||rbp@abpbrasil.org.br
_version_ 1754212556742852608